Korean J Urol.  2013 Jun;54(6):351-358.

Review of Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia

• Osterberg
• Choi BB

Abstract

The gold standard for symptomatic relief of bladder outlet obstruction secondary to benign prostatic hyperplasia has traditionally been a transurethral resection of the prostate (TURP). Over the past decade, however, novel laser technologies that rival the conventional TURP have multiplied. As part of the ongoing quest to minimize complications, shorten hospitalization, improve resection time, and most importantly reduce mortality, laser prostatectomy has continually evolved. Today, there are more variations of laser prostatectomy, each with several differing surgical techniques. Although abundant data are available confirming the safety and feasibility of the various laser systems, future randomized-controlled trials will be necessary to verify which technique is superior. In this review, we describe the most common modalities used to perform a laser prostatectomy, mainly, the holmium laser and the potassium-titanyl-phosphate lasers. We also highlight the physical and clinical characteristics of each technology with a review of the most current and highest-quality literature.

Keyword

Laser surgery; Lower urinary tract symptoms; Prostatic hyperplasia; Transurethral prostatectom

MeSH Terms

Hospitalization
Laser Therapy
Lasers, Solid-State
Lower Urinary Tract Symptoms
Prostate
Prostatectomy
Prostatic Hyperplasia
Transurethral Resection of Prostate
Urinary Bladder Neck Obstruction

Reference

1. Rocco B, Albo G, Ferreira RC, Spinelli M, Cozzi G, Dell'orto P, et al. Recent advances in the surgical treatment of benign prostatic hyperplasia. Ther Adv Urol. 2011; 3:263–272. PMID: 22164196.

2. Chung DE, Te AE. New techniques for laser prostatectomy: an update. Ther Adv Urol. 2009; 1:85–97. PMID: 21789057.

3. Uchida T, Egawa S, Iwamura M, Ohori M, Yokoyama E, Endo T, et al. A non-randomized comparative study of visual laser ablation and transurethral resection of the prostate in benign prostatic hyperplasia. Int J Urol. 1996; 3:108–112. PMID: 8689503.

4. Cowles RS 3rd, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology. 1995; 46:155–160. PMID: 7542818.

5. Donovan JL, Peters TJ, Neal DE, Brookes ST, Gujral S, Chacko KN, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study. J Urol. 2000; 164:65–70. PMID: 10840426.

6. Gilling PJ, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol. 1996; 10:459–461. PMID: 8905494.

7. Suardi N, Gallina A, Salonia A, Briganti A, Deho F, Zanni G, et al. Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome. Curr Opin Urol. 2009; 19:38–43. PMID: 19057214.

8. Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P, et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol. 1999; 13:127–130. PMID: 10213108.

9. Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR. Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int. 2003; 92:707–709. PMID: 14616451.

10. Kumar SM. Rapid communication: holmium laser ablation of large prostate glands: an endourologic alternative to open prostatectomy. J Endourol. 2007; 21:659–662. PMID: 17638566.

11. Elzayat EA, Al-Mandil MS, Khalaf I, Elhilali MM. Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial. J Urol. 2009; 182:133–138. PMID: 19447438.

12. Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, et al. Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients. World J Urol. 2012; 7. 11. [Epub]. http://dx.doi.org/10.1007/s00345-012-0901-6.

13. Jumper C, Snyder P, Yap RL. Rapid ambulatory pathway laser prostatectomy is safe: results within the global period. BJU Int. 2012; 110:1190–1193. PMID: 22372831.

14. Mackey MJ, Chilton CP, Gilling PJ, Fraundorfer M, Cresswell MD. The results of holmium laser resection of the prostate. Br J Urol. 1998; 81:518–519. PMID: 9598619.

15. Son H, Song SH, Paick JS. Current laser treatments for benign prostatic hyperplasia. Korean J Urol. 2010; 51:737–744. PMID: 21165192.

16. Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol. 2008; 53:744–749. PMID: 17475395.

17. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol. 2006; 50:563–568. PMID: 16713070.

18. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008; 53:160–166. PMID: 17869409.

19. Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2006; 175:1428–1432. PMID: 16516015.

20. Rigatti L, Naspro R, Salonia A, Centemero A, Ghezzi M, Guazzoni G, et al. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology. 2006; 67:1193–1198. PMID: 16750253.

21. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006; 50:569–573. PMID: 16704894.

22. Mavuduru RM, Mandal AK, Singh SK, Acharya N, Agarwal M, Garg S, et al. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int. 2009; 82:130–135. PMID: 19321996.

23. Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2008; 179(5 Suppl):S87–S90. PMID: 18405765.

24. Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007; 52:1456–1463. PMID: 17499427.

25. Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006; 175:1817–1821. PMID: 16600770.

26. Shah HN, Mahajan AP, Hegde SS, Bansal MB. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007; 100:94–101. PMID: 17419697.

27. Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol. 2006; 24:405–409. PMID: 16699795.

28. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology. 1998; 51:254–256. PMID: 9495707.

29. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000; 163:1730–1733. PMID: 10799170.

30. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003; 17:93–96. PMID: 12689402.

31. Araki M, Lam PN, Wong C. High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. J Endourol. 2008; 22:1311–1314. PMID: 18484893.

32. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol. 2005; 48:608–613. PMID: 16135396.

33. Tugcu V, Tasci AI, Sahin S, Ordekci Y, Karakas OF, Zorluoglu F. Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int. 2007; 79:316–320. PMID: 18025849.

34. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004; 172(4 Pt 1):1404–1408. PMID: 15371855.

35. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004; 64:1155–1159. PMID: 15596189.

36. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int. 2007; 100:593–598. PMID: 17511771.

37. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005; 173:158–160. PMID: 15592063.

38. Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol. 2011; 186:977–981. PMID: 21791350.

39. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005; 174(4 Pt 1):1344–1348. PMID: 16145416.

40. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology. 2009; 73:807–810. PMID: 19200589.

41. Paick JS, Um JM, Kim SW, Ku JH. Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med. 2007; 4:1701–1707. PMID: 17672845.

42. Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol. 2006; 176(4 Pt 1):1500–1506. PMID: 16952668.

43. Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int. 2008; 102:1432–1438. PMID: 18671785.

44. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010; 105:964–969. PMID: 19912196.

45. Lee R, Saini R, Zoltan E, Te AE. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol. 2008; 180:1551–1553. PMID: 18710776.

46. Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol. 2008; 180:2675–2680. PMID: 18951570.

47. Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012; 61:1165–1173. PMID: 22341632.

48. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010; 58:349–355. PMID: 20605316.

49. Xue B, Zang Y, Zhang Y, Yang D, Gao J, Sun C, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial. J Xray Sci Technol. 2013; 21:125–132. PMID: 23507858.

50. Tao W, Xue B, Zang Y, Sun C, Yang D, Zhang Y, et al. The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci. 2012; 10. 04. [Epub]. http://dx.doi.org/10.1007/s10103-012-1212-2.

51. Sohn JH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS Greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol. 2011; 52:178–183. PMID: 21461281.

52. Chen D, Xue B, Shan Y, Yang D, Sun C, Gao J. GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients. Lasers Med Sci. 2013; 1. 03. [Epub]. http://dx.doi.org/10.1007/s10103-012-1252-7.

53. Choi SW, Choi YS, Bae WJ, Kim SJ, Cho HJ, Hong SH, et al. 120 W Greenlight HPS laser photoselective vaporization of the prostate for treatment of benign prostatic hyperplasia in men with detrusor underactivity. Korean J Urol. 2011; 52:824–828. PMID: 22216394.

54. Malek RS, Kang HW, Peng YS, Stinson D, Beck MT, Koullick E. Photoselective vaporization prostatectomy: experience with a novel 180 W 532 nm lithium triborate laser and fiber delivery system in living dogs. J Urol. 2011; 185:712–718. PMID: 21168876.

55. Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol. 2012; 61:600–607. PMID: 22153927.

56. Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol. 2005; 19:25–31. PMID: 15735378.

57. Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol. 2007; 25:257–262. PMID: 17530258.

58. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol. 2008; 22:1041–1045. PMID: 18377234.

59. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ. Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol. 2009; 27:541–545. PMID: 19184038.

60. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ. Thulium:YAG vaporesection of the prostate. First results. Urologe A. 2009; 48:529–534. PMID: 19183928.

61. Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, et al. Treatment of benign prostatic hyperplasia with the Revolix laser. Arch Esp Urol. 2008; 61:1037–1043. PMID: 19140585.

62. Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol. 2008; 53:382–389. PMID: 17566639.

63. Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology. 2012; 79:869–874. PMID: 22342411.

64. Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, et al. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci. 2009; 24:419–424. PMID: 18685885.

65. Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol. 2009; 182:1078–1082. PMID: 19616811.

66. Yang KS, Seong YK, Kim IG, Han BH, Kong GS. Initial experiences with a 980 nm diode laser for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Korean J Urol. 2011; 52:752–756. PMID: 22195264.

67. Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, et al. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. Eur Urol. 2007; 52:1717–1722. PMID: 17628326.

68. Leonardi R. Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis. 2009; 12:277–280. PMID: 19322136.

69. Ruszat R, Seitz M, Wyler SF, Muller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009; 104:820–825. PMID: 19239441.

70. Chiang PH, Chen CH, Kang CH, Chuang YC. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med. 2010; 42:624–629. PMID: 20806388.

71. Rosenthal BD, DiTrolio JV. Photoselective vaporization of the prostate in office and outpatient settings. Can J Urol. 2012; 19:6223–6226. PMID: 22512971.

72. Buisan O, Saladie JM, Ruiz JM, Bernal S, Bayona S, Ibarz L. Diode laser enucleation of the prostate (Dilep): technique and initial results. Actas Urol Esp. 2011; 35:37–41. PMID: 21256393.

73. Bachmann A, Woo HH, Wyler S. Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence. Curr Opin Urol. 2012; 22:22–33. PMID: 22123291.

74. Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev. 2004; (1):CD001987. PMID: 14973978.

75. Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS. EAU Guidelines Panel on Lasers, Technologies. EAU guidelines on laser technologies. Eur Urol. 2012; 61:783–795. PMID: 22285403.